162 related articles for article (PubMed ID: 38467743)
1. Multiple cancer cell types release LIF and Gal3 to hijack neural signals.
Xu Q; Cao Y; Kong F; Liu J; Chen X; Zhao Y; Lai CH; Zhou X; Hu H; Fu W; Chen J; Yang J
Cell Res; 2024 May; 34(5):345-354. PubMed ID: 38467743
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.
Zhao W; Ajani JA; Sushovan G; Ochi N; Hwang R; Hafley M; Johnson RL; Bresalier RS; Logsdon CD; Zhang Z; Song S
Gastroenterology; 2018 Apr; 154(5):1524-1537.e6. PubMed ID: 29274868
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3 modulates Th17 responses by regulating dendritic cell cytokines.
Fermin Lee A; Chen HY; Wan L; Wu SY; Yu JS; Huang AC; Miaw SC; Hsu DK; Wu-Hsieh BA; Liu FT
Am J Pathol; 2013 Oct; 183(4):1209-1222. PubMed ID: 23916470
[TBL] [Abstract][Full Text] [Related]
4. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
[TBL] [Abstract][Full Text] [Related]
5. Leukemia inhibitory factor inhibits the proliferation of gastric cancer by inducing G1-phase arrest.
Xu G; Wang H; Li W; Xue Z; Luo Q
J Cell Physiol; 2019 Apr; 234(4):3613-3620. PubMed ID: 30565675
[TBL] [Abstract][Full Text] [Related]
6. Galectin-3 accelerates M2 macrophage infiltration and angiogenesis in tumors.
Jia W; Kidoya H; Yamakawa D; Naito H; Takakura N
Am J Pathol; 2013 May; 182(5):1821-31. PubMed ID: 23499465
[TBL] [Abstract][Full Text] [Related]
7. Lack of galectin-3 alters the balance of innate immune cytokines and confers resistance to Rhodococcus equi infection.
Ferraz LC; Bernardes ES; Oliveira AF; Ruas LP; Fermino ML; Soares SG; Loyola AM; Oliver C; Jamur MC; Hsu DK; Liu FT; Chammas R; Roque-Barreira MC
Eur J Immunol; 2008 Oct; 38(10):2762-75. PubMed ID: 18825751
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 negatively regulates TCR-mediated CD4+ T-cell activation at the immunological synapse.
Chen HY; Fermin A; Vardhana S; Weng IC; Lo KF; Chang EY; Maverakis E; Yang RY; Hsu DK; Dustin ML; Liu FT
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14496-501. PubMed ID: 19706535
[TBL] [Abstract][Full Text] [Related]
9. Leukemia inhibitory factor drives glucose metabolic reprogramming to promote breast tumorigenesis.
Yue X; Wang J; Chang CY; Liu J; Yang X; Zhou F; Qiu X; Bhatt V; Guo JY; Su X; Zhang L; Feng Z; Hu W
Cell Death Dis; 2022 Apr; 13(4):370. PubMed ID: 35440095
[TBL] [Abstract][Full Text] [Related]
10. Coordinated expression of galectin-3 and caveolin-1 in thyroid cancer.
Shankar J; Wiseman SM; Meng F; Kasaian K; Strugnell S; Mofid A; Gown A; Jones SJ; Nabi IR
J Pathol; 2012 Sep; 228(1):56-66. PubMed ID: 22513979
[TBL] [Abstract][Full Text] [Related]
11. Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth.
McLean K; Tan L; Bolland DE; Coffman LG; Peterson LF; Talpaz M; Neamati N; Buckanovich RJ
Oncogene; 2019 Feb; 38(9):1576-1584. PubMed ID: 30305729
[TBL] [Abstract][Full Text] [Related]
12. Autocrine Leukemia Inhibitory Factor Promotes Esophageal Squamous Cell Carcinoma Progression via Src Family Kinase-Dependent Yes-Associated Protein Activation.
Kawazoe T; Saeki H; Oki E; Oda Y; Maehara Y; Mori M; Taniguchi K
Mol Cancer Res; 2020 Dec; 18(12):1876-1888. PubMed ID: 33004621
[TBL] [Abstract][Full Text] [Related]
13. Magnolin promotes autophagy and cell cycle arrest via blocking LIF/Stat3/Mcl-1 axis in human colorectal cancers.
Yu H; Yin S; Zhou S; Shao Y; Sun J; Pang X; Han L; Zhang Y; Gao X; Jin C; Qiu Y; Wang T
Cell Death Dis; 2018 Jun; 9(6):702. PubMed ID: 29899555
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3 modulation of T-cell activation: mechanisms of membrane remodelling.
Gilson RC; Gunasinghe SD; Johannes L; Gaus K
Prog Lipid Res; 2019 Oct; 76():101010. PubMed ID: 31682868
[TBL] [Abstract][Full Text] [Related]
15. Galectin-3 mediates survival and apoptosis pathways during Trypanosoma cruzi-host cell interplay.
Chain MO; Paiva CAM; Maciel IO; Neto AN; Castro VF; Oliveira CP; Mendonça BDS; Nestal de Moraes G; Reis SAD; Carvalho MA; De-Melo LDB
Exp Parasitol; 2020 Sep; 216():107932. PubMed ID: 32535113
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylated galectin-3 mediates tumor necrosis factor-related apoptosis-inducing ligand signaling by regulating phosphatase and tensin homologue deleted on chromosome 10 in human breast carcinoma cells.
Mazurek N; Sun YJ; Liu KF; Gilcrease MZ; Schober W; Nangia-Makker P; Raz A; Bresalier RS
J Biol Chem; 2007 Jul; 282(29):21337-48. PubMed ID: 17420249
[TBL] [Abstract][Full Text] [Related]
17. Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment.
Bendtsen SK; Perez-Penco M; Hübbe ML; Martinenaite E; Orebo Holmström M; Weis-Banke SE; Grønne Dahlager Jørgensen N; Jørgensen MA; Munir Ahmad S; Jensen KM; Friese C; Lundsager MT; Johansen AZ; Carretta M; Ødum N; Met Ö; Svane IM; Madsen DH; Andersen MH
Oncoimmunology; 2022; 11(1):2026020. PubMed ID: 35111385
[TBL] [Abstract][Full Text] [Related]
18. Examination of pathways involved in leukemia inhibitory factor (LIF)-induced cell growth arrest using label-free proteomics approach.
Ali SA; Kaur G; Kaushik JK; Malakar D; Mohanty AK; Kumar S
J Proteomics; 2017 Sep; 168():37-52. PubMed ID: 28755912
[TBL] [Abstract][Full Text] [Related]
19. Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunity.
Bernardes ES; Silva NM; Ruas LP; Mineo JR; Loyola AM; Hsu DK; Liu FT; Chammas R; Roque-Barreira MC
Am J Pathol; 2006 Jun; 168(6):1910-20. PubMed ID: 16723706
[TBL] [Abstract][Full Text] [Related]
20. Tumor-derived LIF promotes chemoresistance via activating tumor-associated macrophages in gastric cancers.
Yu S; Li Q; Wang Y; Cui Y; Yu Y; Li W; Liu F; Liu T
Exp Cell Res; 2021 Sep; 406(1):112734. PubMed ID: 34265288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
